“This is more than a regulatory milestone. It represents two decades of focused effort to improve hip resurfacing through an advanced material,” said Mike Tuke, Founder of MatOrtho. “That became a possibility with BIOLOX® delta and cooperation with CeramTec A.G. which led in stages to ReCerf – an all-ceramic resurfacing implant that is already delivering excellent results. We’re proud to make this more widely available to specialist hip resurfacing surgeons, and patients who want to stay active.”

ReCerf is the world’s first commercially available ceramic HRA, first approved by Australia’s Therapeutic Goods Administration in November 2024. Since its initial use in 2018, over 1,600 patients have received the device. Patient-reported outcomes are highly positive, and the revision rate remains very low up to six years.